Azitra (AZTR) Current Assets (2022 - 2026)
Azitra (AZTR) posted Current Assets of $10.8 million for Q1 2026, up 256.38% on a QoQ basis from $3.0 million in Q4 2025, and up 177.93% year-over-year from $3.9 million in Q1 2025.
Azitra (AZTR) Current Assets (2022 - 2026) Analysis & Trends
Azitra's Current Assets history runs 5 years deep, the most recent figure standing at $10.8 million for Q1 2026.
- Quarterly Current Assets rose 177.93% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (up 177.93% YoY) and the FY2025 annual result came in at $3.0 million, down 42.25% from the prior year.
- Current Assets was $10.8 million for Q1 2026 at Azitra, up from $3.0 million in the prior quarter.
- Across five years, Current Assets topped out at $10.8 million in Q1 2026 and bottomed at $1.3 million in Q2 2024.
- A 5-year average of $4.4 million and a median of $3.9 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets tumbled 80.47% — and 2026, when it jumped 177.93%.
- Azitra's Current Assets stood at $4.1 million in 2022, then slumped by 38.69% to $2.5 million in 2023, then surged by 106.2% to $5.2 million in 2024, then sank by 42.25% to $3.0 million in 2025, then jumped by 256.38% to $10.8 million in 2026.
- Business Quant data shows AZTR's Current Assets at $10.8 million in Q1 2026, $3.0 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - | 71.41 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 3.59 Mn |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn | 6.60 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn | 11.73 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn | 18.21 Bn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - | 521.86 Mn |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn | 8.07 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | 4.22 Bn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - | 1.97 Bn |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - | 10.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.76 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 5.23 Mn |
| Sep 30, 2024 | 7.63 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 2.54 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | 6.84 Mn |
| Dec 31, 2022 | 4.14 Mn |